Boardroom Alpha
Meeting calendar
CMCO · Annual meeting · Friday, August 15, 2025

Columbus Mckinnon Corp

9 nominees · 7 ballot items.

Proposals presented at the 2025 Columbus McKinnon annual meeting include: Proposal 1 election of Directors; Proposal 2 advisory Say-on-Pay on named executive officer compensation; Proposal 3 ratification of Ernst & Young LLP as independent auditor; Proposal 4 Nasdaq Listing Rules elimination (Nasdaq Cap) for conversion and voting of Series A Preferred Shares; Proposal 5 Authorized Shares Increase; Proposal 6 CD&R Investors Preemptive Rights; and Proposal 7 Adjournment of the meeting if necessary.

Market cap
$418M
1Y TSR
-4.1%
Board grade
B-
Record date
Jun 16, 2025
Filing
DEF 14A
Meeting concluded · Aug 15, 2025

Follow how the vote landed and what changed on Columbus Mckinnon Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot7

  1. 1

    Election of Directors

    ManagementBoard: FOR

    To elect nine Directors to hold office until the 2026 Annual Meeting and until their successors have been elected and qualified.

  2. 2

    Advisory Vote on the Compensation of Our Named Executive Officers

    ManagementBoard: FOR

    The advisory vote on the compensation of our named executive officers is a non-binding vote on the compensation disclosed in this proxy statement.

  3. 3

    Ratification of the Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    The ratification of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026.

  4. 4

    Nasdaq Listing Rules Proposal

    ManagementBoard: FOR

    To eliminate restrictions on the issuance of common stock in connection with the conversion of the Preferred Shares and on the voting of Preferred Shares for Nasdaq Listing Rule 5635 compliance.

  5. 5

    Authorized Shares Proposal

    ManagementBoard: FOR

    To amend the Restated Certificate of Incorporation to increase the number of authorized common stock from 50,000,000 to 100,000,000 and the total authorized shares from 51,000,000 to 101,000,000.

  6. 6

    Preemptive Rights Proposal

    ManagementBoard: FOR

    To amend the Restated Certificate of Incorporation to permit exercise of preemptive rights by the CD&R Investors in connection with their contractual rights under the Investment Agreement.

  7. 7

    Adjournment Proposal

    ManagementBoard: FOR

    To adjourn the Annual Meeting to a later date, if necessary, to permit further solicitation of proxies.

Director elections

Nominees on the ballot9

Independent
Tenure on this board
4.6 yrs
Also a director at
Mks Inc (MKSI)
Independent
Tenure on this board
8.7 yrs
Also a director at
Generac Holdings Inc (GNRC)
Not independent
Tenure on this board
6.1 yrs
Also a director at
Modine Manufacturing Co (MOD)Microbot Medical Inc (MBOT)
Independent
Tenure on this board
8.1 yrs
Also a director at
Graphic Packaging Holding Co (GPK)
Independent
Tenure on this board
6.3 yrs
Also a director at
Edison International (EIX)
Independent
Tenure on this board
5.1 yrs
Also a director at
Jabil Inc (JBL)
Independent
Tenure on this board
4.6 yrs
Also a director at
Piper Sandler Companies (PIPR)
Ownership

Top institutional holders10

Latest 13F quarter
1MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6.1%1,766,235$26M
2DIMENSIONAL FUND ADVISORS LP4.5%1,307,883$19M
3VANGUARD CAPITAL MANAGEMENT LLC4.2%1,214,616$18M
4AQR CAPITAL MANAGEMENT LLC3.9%1,126,958$16M
5BlackRock, Inc.3.8%1,082,378$16M
6Blue Grotto Capital, LLC3.4%981,073$14M
7BlackRock, Inc.2.9%840,500$12M
8Stanley Capital Management, LLC2.5%725,000$11M
9Diameter Capital Partners LP2.5%715,783$10M
10HEARTLAND ADVISORS INC2.4%694,050$10M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Columbus Mckinnon Corp 2025 annual meeting?
Columbus Mckinnon Corp (CMCO) holds its 2025 annual shareholder meeting on Friday, August 15, 2025.
What is the record date for the Columbus Mckinnon Corp 2025 meeting?
The record date for the Columbus Mckinnon Corp 2025 meeting is Monday, June 16, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Columbus Mckinnon Corp's 2025 meeting?
The board is presenting 9 director nominees at the Columbus Mckinnon Corp 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Columbus Mckinnon Corp 2025 meeting?
Shareholders will vote on 7 proposals at the Columbus Mckinnon Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer